Presentation: Vaccine development using two immunopotent viral vectors

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Sarah Gilbert from The Jenner Institute entitiled: ‘Vaccine development using two immunopotent viral vectors; …